About Antares Pharma
Antares Pharma is a company based in Ewing (United States) founded in 2000 was acquired by Halozyme in April 2022. Antares Pharma offers products and services including ENHANZE, Auto-Injector, and Multi-Dose Pen.
- Headquarter Ewing, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Antares Pharma, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Antares Pharma
Antares Pharma offers a comprehensive portfolio of products and services, including ENHANZE, Auto-Injector, and Multi-Dose Pen.
Enhances drug administration for improved treatment efficacy.
Facilitates self-injection of medications for patient convenience.
Enables multiple doses in a single device for easier management.
People of Antares Pharma
Unlock access to complete
Unlock access to complete
Funding Insights of Antares Pharma
Investors in Antares Pharma
Antares Pharma has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Halozyme, Hercules Capital and Ferring Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt financing is provided to companies in multiple sectors.
|
Locked | Locked | Locked | |
|
Provider of drugs in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopaedics
|
Locked | Locked | Locked | |
|
Drug delivery technologies for disease treatment are developed.
|
Locked | Locked | Locked |
Investor details for Antares Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Antares Pharma
Investment portfolio details for Antares Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Antares Pharma
Detailed financials for Antares Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Antares Pharma Comparisons
Peer comparison for Antares Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Antares Pharma
Detailed competitors of Antares Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Antares Pharma
Complete news archive for Antares Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Antares Pharma
Antares Pharma was founded in 2000 and raised its 1st funding round 7 years after it was founded.
Antares Pharma is headquartered in Ewing, United States. It is registered at Ewing, New Jersey, United States.
Annual revenue of Antares Pharma is $183.98M as on Dec 31, 2021.
Antares Pharma was established in 2000 in Ewing, United States, within the pharmaceuticals sector focused on drug delivery systems. Existing medications are reformulated through the VIBEX platform, featuring pre-filled pen injectors for intradermal, subcutaneous, or intramuscular administration. Collaborations are formed with pharmaceutical partners to adapt their products. The development pipeline encompasses injectors for human growth hormone from Ferring, estradiol from Meda, Gelnique from Actavis, and methotrexate.
Antares Pharma offers ENHANZE, Auto-Injector, and Multi-Dose Pen.
Antares Pharma has 3 investors. Key investors include Halozyme, Hercules Capital, and Ferring Pharmaceuticals.